Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 73 filings·Updated 24 Aug 2026
Showing 10 of 73 filings.
24 Aug 20262 filings
Company UpdateOptions to purchase securities

Zensar approves ESOP allotment; issued capital increases on Aug 24, 2026

Capital / Securities

  • Aug 24, 2026: Nomination and Remuneration Committee approved allotment of 25,691 equity shares on ESOP exercise.
  • Consequently, on Aug 24, 2026, issued capital increased to Rs 455,161,426 comprising 227,580,713 equity shares.
Filed 19:24View Source
Company UpdateAllotment of ESOP / ESPS

Intimation about allotment of Equity Shares by the Nomination and Remuneration Committee

Filed 19:12View Source
14 Aug 20262 filings
Company UpdateGeneral

M3BI merger with Zensar Technologies Inc. becomes effective Sep 1, 2026; Bridgeview filings completed

US subsidiary mergers

  • M3BI LLC merger with Zensar Technologies Inc. becomes effective on September 1, 2026.
  • Bridgeview Life Sciences LLC merger filings completed with Zensar Technologies Inc.
  • All requisite local filings for both mergers completed; post-merger filings remain in process.
  • Intimation of M3BI merger received at 1:43 a.m. IST on August 14, 2026.
Filed 13:17View Source
Company UpdateGeneral

Mergers of Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. filings completed; M3BI effective Sept 1, 2026

US subsidiary mergers status

  • Mergers of Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. have completed requisite filings.
  • M3BI LLC merger with Zensar Technologies Inc. becomes effective from September 1, 2026.
  • Bridgeview Life Sciences LLC merger filings completed; post-merger and consequential filings remain in process.
Filed 13:16View Source
10 Aug 20261 filing
Company UpdateAnalyst / Investor Meet

Zensar to hold group investor meetings at Equirus and Emkay conferences in Aug 2026.

Meeting Details

  • Aug 13, 2026, 1:00 p.m. onwards; Equirus Annual India Conference 2026; In-person group meeting; Purpose: investor interaction.
  • Aug 14, 2026, 10:00 a.m. onwards; Emkay Confluence 2026 – India: Full Throttle Ahead; Purpose: investor interaction.
Filed 13:38View Source
8 Aug 20262 filings
Company UpdateNewspaper Publication

Newspaper Advertisement in respect to a special window opened for lodgement of transfer and dematerialization request(s)

Filed 14:22View Source
Company UpdateCopy of Newspaper Publication

Zensar Technologies Limited has informed the Exchange about Copy of Newspaper Publication in respect to a special window opened for lodgementof transfer and dematerialization ( demat ) request(s)

Filed 14:14View Source
31 Jul 20262 filings
Company UpdateCopy of Newspaper Publication

Zensar Technologies Limited has informed the Exchange about Copy of Newspaper Publication

Filed 15:34View Source
Company UpdateNewspaper Publication

Copies of newspaper advertisement of the unaudited Financial Results published in Financial Express (all India edition) and Loksatta (Pune edition) on July 31, 2026 which were approved ....

Filed 15:28View Source
30 Jul 20261 filing
Company UpdateAnalyst / Investor Meet

Audio recording of Zensar Q1FY27 earnings call held July 30, 2026 now available

Meeting Details

  • Date and time: July 30, 2026, 08:30 IST.
  • Type and mode: earnings call, audio recording.
  • Event organiser: Q1FY27 earnings call by Zensar Technologies.
  • Key company participant: Company Secretary.
  • Purpose: discuss Q1FY27 results, quarter ended June 30, 2026.
  • Availability: recording updated on Investors Corner website.

Participants

  • Key participant: Company Secretary (management role).

Purpose

  • Discuss Q1FY27 results, quarter ended June 30, 2026.

Additional Notes

  • Recording available on the company's Investors Corner.
  • Transcript not mentioned.
Filed 11:20View Source
Showing 10 of 73 filings